|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| G01N 33/574 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3331915 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16757165.2 |
| Date of filing the European patent application | 2016-08-05 | |
| (97) | Date of publication of the European application | 2018-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-17 |
| (46) | Date of publication of the claims translation | 2021-06-10 |
| (86) | Number | PCT/EP2016/068726 |
| Date | 2016-08-05 |
| (87) | Number | WO 2017/021526 |
| Date | 2017-02-09 |
| (30) | Number | Date | Country code |
| 201562201461 P | 2015-08-05 | US |
| (72) |
FIEDLER, Walter, DE
WELLBROCK, Jasmin, DE
STAMM, Hauke, DE
KLINGLER, Felix, DE
|
| (73) |
Amgen Research (Munich) GmbH,
Staffelseestrasse 2, 81477 München,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Imuninio atsako kontrolinio taško inhibitoriai, skirti naudoti gydant kraujodaros prigimties vėžio formas |
| IMMUNE-CHECKPOINT INHIBITORS FOR USE IN THE TREATMENT OF BLOOD-BORNE CANCERS |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 10 | 231.00 EUR |
| 2026-08-05 |